SPONSOR
Imperial College London
Total Trials
11
Recruiting
11
Phases
N/A
Conditions studied: Infections, BacterialPharmacokineticsDrug MonitoringDrug-Related Side Effects and Adverse ReactionsCancerRectal CancerBrain Metastases, AdultBreast CancerCardiovascular DiseasesHealthy Volunteers
Imperial College London is a clinical research sponsor with 11 registered studies on ClinicalTrials.gov, of which 11 are actively recruiting participants. Research covers conditions including Infections, Bacterial, Pharmacokinetics, Drug Monitoring, Drug-Related Side Effects and Adverse Reactions.
Studies span multiple clinical phases, reflecting a pipeline that may include early-stage safety evaluations, mid-stage efficacy assessments, and large-scale confirmatory trials. All studies listed here are sourced directly from ClinicalTrials.gov and updated daily.
Frequently Asked Questions — Imperial College London
How many clinical trials has Imperial College London sponsored?
ClinicalMetric currently tracks 11 clinical trials sponsored by Imperial College London, of which 11 are actively recruiting participants. These trials cover conditions including Infections, Bacterial, Pharmacokinetics, Drug Monitoring. Trial counts are updated daily from ClinicalTrials.gov and reflect currently registered studies.
What therapeutic areas does Imperial College London research focus on?
Imperial College London clinical trials span Infections, Bacterial, Pharmacokinetics, Drug Monitoring, Drug-Related Side Effects and Adverse Reactions, Cancer, and additional conditions. Sponsor focus areas evolve as trials complete and new programs launch.
How do I participate in a Imperial College London clinical trial?
To participate in a Imperial College London trial, review the active studies listed on this page, check each trial's specific eligibility criteria on ClinicalTrials.gov, and contact the trial site directly—not the sponsor's headquarters. Trial sites are academic medical centers, hospitals, or specialized research clinics. Your physician can facilitate a referral. ClinicalMetric lists all Imperial College London trials with current recruitment status updated daily.
Clinical Trials by Imperial College London
NCT06427317
Recruiting
Routinely Collected Clinical Data and Evaluation of Antimicrobial Target Attainment
Infections, Bacterial
NCT02579278
Recruiting
Circulating Tumour DNA (ctDNA) in Patients With Colorectal Cancer and the Relationship to Imaging Features of Extramural Venous Invasion
Cancer
NCT06611306
Recruiting
BEAT-Breast: Trial of DE-iPTV in Patients With Primary Breast Cancer With Brain Metastases Who Are Not Suitable for Stereotactic Radiotherapy.
Brain Metastases, Adult
NCT06061822
Recruiting
Artificial Intelligence Delivered Cardiac Magnetic Resonance - Prospective Validation
Cardiovascular Diseases
NCT07057466
Recruiting
Prospective Evaluation of AI-ECG for SHD Detection
Valvular Heart Disease Stenosis and Regurgitation (Diagnosis)
NCT07192393
Recruiting
Health-Related Quality-of-Life and Household Financial and Wellbeing Impacts of Prematurity and Necrotising Enterocolitis (NEC).
Prematurity; Extreme
NCT02246634
Recruiting
Screening for Synchronous Metastases in Colorectal Cancer With DW-MRI (SERENADE)
Colorectal Neoplasms
NCT06463483
Recruiting
Automated Insulin Delivery in Adults With Advanced Kidney Disease
Chronic Kidney Diseases
NCT00230620
Recruiting
Molecular Studies on Hereditary Haemorrhagic Telangiectasia Families
Telangiectasia, Hereditary Hemorrhagic
NCT05404061
Recruiting
The Poor Responders Study
Bariatric Surgery Candidate
NCT07243262
Recruiting
Volatile Organic Compound Assessment in Pancreatic Ductal Adenocarcinoma (VAPOR2)
Pancreatic Cancer
ClinicalMetric — Independent clinical trial intelligence platform. Not affiliated with NIH, ClinicalTrials.gov, the U.S. FDA, or any pharmaceutical company, hospital, or clinical research organization. Trial data is sourced from ClinicalTrials.gov for informational purposes only and does not constitute medical advice. Do not make any treatment, enrollment, or health decisions based solely on information found here — always consult a qualified healthcare professional. Full Disclaimer · Last Reviewed: November 2026 · Data Methodology